A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Sanofi to conduct Phase 3 clinical trial to evaluate subcutaneous vs intravenous administration of Isatuximab with Pomalidomide and Dexamethasone in adults with relapsed or refractory multiple myeloma; recruitment has not yet started

Gsk Announces Positive Phase Iii Data For Rsv Vaccine Candidate For Older Adults

Gerresheimer signs agreement with drug development firm ISR for large-scale production of IcoOne nasal inhaler for ISR’s Phase 3 study of its dry powder COVID-19 vaccine; Gerresheimer has annual production capacity of more than 100 million inhalers

Pfizer partners with Northern Light Health in Brewer, Maine, to conduct third phase of Lyme disease vaccine clinical trial involving about 100 people, with registration starting in July; Maine has highest rate of Lyme disease infections in US

Janssen to conduct Phase 3 trial to study injectable Lazertinib with subcutaneous amivantamab to treat egfr-mutated advanced, metastatic non-small cell lung cancer; drug to be administered after patient progresses on Osimertinib, chemotherapy

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count